Moran Wealth Management’s Meridian Bioscience Inc VIVO Stock Holding History

Moran Wealth Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,085	Closed	-$269K	–	383
2022 Q4	$269K	Buy	+8,085	New	+$260K	0.01%	325

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Moran Wealth Management's VIVO Position: Q1 2023 in Review

Moran Wealth Management sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 8,085 shares — an estimated $269K sold.

Moran Wealth Management first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $269K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Moran Wealth Management reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Moran Wealth Management sold 8,085 Meridian Bioscience Inc shares in Q1 2023, an estimated $269K.
Moran Wealth Management first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Moran Wealth Management's Meridian Bioscience Inc position peaked at $269K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Moran Wealth Management's 13F filing for Q1 2023, filed 10 May 2023.